ES2262801T3 - Uso de un compuesto de carbamato para la prevencion o el tratamiento de trastorno bipolar. - Google Patents

Uso de un compuesto de carbamato para la prevencion o el tratamiento de trastorno bipolar.

Info

Publication number
ES2262801T3
ES2262801T3 ES02724984T ES02724984T ES2262801T3 ES 2262801 T3 ES2262801 T3 ES 2262801T3 ES 02724984 T ES02724984 T ES 02724984T ES 02724984 T ES02724984 T ES 02724984T ES 2262801 T3 ES2262801 T3 ES 2262801T3
Authority
ES
Spain
Prior art keywords
formula
enantiomer
phenyl
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02724984T
Other languages
English (en)
Spanish (es)
Inventor
Carlos R. Plata-Salaman
Boyu Zhao
Roy E. Twyman
Yong Moon Choi
Robert Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of ES2262801T3 publication Critical patent/ES2262801T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
ES02724984T 2001-02-27 2002-02-21 Uso de un compuesto de carbamato para la prevencion o el tratamiento de trastorno bipolar. Expired - Lifetime ES2262801T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US271681P 2001-02-27
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
PCT/US2002/005297 WO2002067921A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number Publication Date
ES2262801T3 true ES2262801T3 (es) 2006-12-01

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02724984T Expired - Lifetime ES2262801T3 (es) 2001-02-27 2002-02-21 Uso de un compuesto de carbamato para la prevencion o el tratamiento de trastorno bipolar.

Country Status (26)

Country Link
US (1) US6562867B2 (enExample)
EP (1) EP1408953B1 (enExample)
JP (1) JP4276837B2 (enExample)
KR (1) KR100946944B1 (enExample)
CN (1) CN1250215C (enExample)
AT (1) ATE324108T1 (enExample)
BR (1) BR0207644A (enExample)
CA (1) CA2439475C (enExample)
CY (1) CY1105330T1 (enExample)
CZ (1) CZ20032300A3 (enExample)
DE (1) DE60210976T2 (enExample)
DK (1) DK1408953T3 (enExample)
ES (1) ES2262801T3 (enExample)
HU (1) HUP0303243A3 (enExample)
IL (1) IL157590A0 (enExample)
MX (1) MXPA03007717A (enExample)
MY (1) MY129304A (enExample)
NO (1) NO20033802L (enExample)
NZ (1) NZ527988A (enExample)
PL (1) PL364638A1 (enExample)
PT (1) PT1408953E (enExample)
RS (1) RS50677B (enExample)
RU (1) RU2300372C2 (enExample)
TW (1) TWI250872B (enExample)
WO (1) WO2002067921A1 (enExample)
ZA (1) ZA200307465B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7349301A (en) * 2000-07-21 2002-02-05 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MXPA03007720A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
RS51055B (sr) * 2001-02-27 2010-10-31 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neurodegenerativnih poremećaja
ATE435014T1 (de) 2001-07-16 2009-07-15 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
RS51269B (sr) * 2004-09-16 2010-12-31 Janssen Pharmaceutica N.V. Upotreba 2-fenil-1,2-etandiol-(di)karbamata za tretiranje epileptogeneze
KR101335941B1 (ko) 2005-06-08 2013-12-04 에스케이바이오팜 주식회사 수면-각성 장애의 치료
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
US20080103199A1 (en) * 2006-10-31 2008-05-01 Haas Magali Treatment of pervasive developmental disorders
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US9566261B2 (en) * 2013-03-12 2017-02-14 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
EP3556366B1 (en) 2016-12-14 2025-10-22 SK Biopharmaceuticals Co., Ltd. Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
WO2018222954A1 (en) 2017-06-02 2018-12-06 Jazz Pharmaceuticals International Iii Limited Methods and compositions for treating excessive sleepiness
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
ATE182332T1 (de) * 1994-06-16 1999-08-15 Pfizer Pyrazolo und pyrrolopyridine
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
ZA200307465B (en) 2005-03-17
DE60210976T2 (de) 2007-05-24
BR0207644A (pt) 2004-03-09
RU2003128997A (ru) 2005-03-20
US20020198257A1 (en) 2002-12-26
EP1408953B1 (en) 2006-04-26
MXPA03007717A (es) 2005-11-08
NZ527988A (en) 2006-01-27
HUP0303243A3 (en) 2012-07-30
IL157590A0 (en) 2004-03-28
PL364638A1 (en) 2004-12-13
CZ20032300A3 (cs) 2005-01-12
TWI250872B (en) 2006-03-11
HK1063436A1 (en) 2004-12-31
JP4276837B2 (ja) 2009-06-10
CA2439475A1 (en) 2002-09-06
US6562867B2 (en) 2003-05-13
YU67803A (sh) 2006-08-17
CN1505506A (zh) 2004-06-16
WO2002067921A1 (en) 2002-09-06
CY1105330T1 (el) 2010-03-03
NO20033802L (no) 2003-10-22
CA2439475C (en) 2010-05-18
DK1408953T3 (da) 2006-08-21
RS50677B (sr) 2010-06-30
NO20033802D0 (no) 2003-08-26
KR100946944B1 (ko) 2010-03-15
ATE324108T1 (de) 2006-05-15
RU2300372C2 (ru) 2007-06-10
EP1408953A1 (en) 2004-04-21
MY129304A (en) 2007-03-30
KR20030087010A (ko) 2003-11-12
HUP0303243A2 (hu) 2004-01-28
DE60210976D1 (de) 2006-06-01
CN1250215C (zh) 2006-04-12
JP2004533415A (ja) 2004-11-04
PT1408953E (pt) 2006-07-31

Similar Documents

Publication Publication Date Title
ES2262801T3 (es) Uso de un compuesto de carbamato para la prevencion o el tratamiento de trastorno bipolar.
ES2295320T3 (es) Compuestos de carbamato utiles para prevenir o tratar el trastorno bipolar.
ES2284845T3 (es) Uso de un compuesto de carbamato para la prevencion y el tratamiento de enfermedades neurodegenerativas.
AU2002242226A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
PT1411917E (pt) ''compostos carbamatos para utilização na prevenção ou tratamento de distúrbios do movimento''
ES2356617T3 (es) Compuestos de carbamato para su uso en el tratamiento del dolor.
ES2385087T3 (es) Procedimientos para tratar trastornos relacionados con sustancias
ES2262826T3 (es) Uso de un compuesto de carbamato en la prevencion o el tratamiento de transtornos de ansiedad.
KR20030022300A (ko) 신경병증 통증 및 군발성 및 편두통성 두통-관련 통증의예방 또는 치료를 위해 사용하기 위한 카바메이트 화합물
ES2327721T3 (es) Compuestos de carbamato para uso en la prevencion o tratamiento del dolor neuropatico.
AU2002255580B2 (en) Carbamate compounds for use in preventing or treating bipolar disorder
ES2278035T3 (es) Compuestos de carbamato destinados a ser utilizados en la prevencion o el tratamiento del dolor neuropatico y del dolor asociado a las cefaleas agrupadas y por migrañas.
AU2002255580A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
HK1063436B (en) Carbamate compounds for use in preventing or treating bipolar disorder
HK1058762B (en) Carbamate compounds for use in preventing or treating bipolar disorder